Management of AIDS-Defining Cancers

  • Authors: David Aboulafia, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/18 (What's New)

Summary

  • Autologous hematopoietic stem cell transplantation considered standard of care for treatment of refractory or relapsed DLBCL in patients with chemosensitive disease and well-controlled HIV viremia[Alvarnas 2017; Alvarnas 2016; Diez-Martin 2009; Krishnan 2010; Bortolin 2010]
  • Platinum-containing chemotherapy regimens may also be appropriate for relapsed/refractory lymphomas[Kaplan 2012]
  • Patients who are unable to receive additional chemotherapy should be referred for hospice care

Action required

Keywords: Cancer

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.